Acute Respiratory Disease as a Fulcrum Point to Quit Smoking: Evaluation of an ED-based Intervention

NCT ID: NCT06923852

Last Updated: 2025-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

288 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-10

Study Completion Date

2017-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate smoking cessation success rates using the Fagerström Test for Nicotine Dependence (FTND) in smoking cessation treatment. The study has a retrospective design, analyzing data from patients who applied to a smoking cessation clinic to investigate the impact of nicotine dependence severity on quitting success.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Emergency departments (EDs) are among the most critical referral centers for individuals with health problems resulting from the direct and indirect effects of smoking. Individuals may be more motivated to change their smoking habits, especially during acute attacks of respiratory diseases. The American College of Emergency Physicians (ACEP) and some organizations recommend that interventions for smoking cessation should be implemented by physicians and nurses in the form of counseling for patients with active smoking who receive treatment for acute respiratory infections (ARI) in EDs. However, interventions for smoking cessation are frequently performed in primary health care institutions and according to studies, a high majority of emergency physicians think that EDs are not the appropriate place for this intervention and are not included in their professional responsibilities.

The effect of nicotine dependence (ND) severity on smoking cessation has been shown in studies. Fagerström Test of Nicotine Dependence (FTND) developed by Fagerström et al. is a widely used tool to measure the ND level of individuals. The Turkish validity and reliability study of the test was conducted by Uysal et al. In the approach to smoking cessation, ND level comes to the forefront in determining personalized intervention strategies. At high levels of addiction, nicotine replacement therapy or pharmacologic support is recommended because the physical and psychological dependence of individuals is more intense. In these cases, motivational counseling and regular follow-up are necessary during the cessation process. At moderate levels of addiction, nicotine replacement products or behavioral therapies are usually recommended, while less pharmacological intervention may be required. At low levels of addiction, behavioral support and counseling may be sufficient for smoking cessation. Pharmacologic treatment is usually not needed in these individuals, but education and awareness-raising methods that support smoking cessation can be used. Intervention with strategies appropriate to the level of ND is a crucial factor in increasing the success of smoking cessation.

When determining the assistance method in individuals who want to quit smoking; WHO recommends five major steps (5A) in smoking cessation treatment. In practice, the "Ask, Advise, Assess, Assist, Arrange" approach is an evidence-based smoking cessation model that has been developed to provide effective interventions in a short time, especially in busy working environments.

This study aimed to examine the effects of short structured interviews with patients who presented to the ED due to ARI on smoking cessation behavior and to follow up for one month. It is aimed to evaluate the applicability of smoking cessation interventions on those with ARI in EDs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation Emergency Department Visit Acute Respiratory Infections (ARIs)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active smokers who attend the emergency depertment with acute respiratory infections

Smoking cessation support that World Health Organization (WHO) 5A model (Ask, Advise, Assess, Assist, Arrange).

Intervention Type BEHAVIORAL

Smoking cessation support that World Health Organization (WHO) 5A model (Ask, Advise, Assess, Assist, Arrange).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smoking cessation support that World Health Organization (WHO) 5A model (Ask, Advise, Assess, Assist, Arrange).

Smoking cessation support that World Health Organization (WHO) 5A model (Ask, Advise, Assess, Assist, Arrange).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were active smokers and admitted to the emergency department with acute respiratory system complaints.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seda Oğuz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seda Oğuz

Emergency Physician

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMOKE-21041991

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Secondhand Smoke Respiratory Health Study
NCT02797275 ACTIVE_NOT_RECRUITING PHASE4
Improving Quitline Support Study
NCT03538938 COMPLETED PHASE4
Enhancing Equity in Smoke-free Housing
NCT06042361 ENROLLING_BY_INVITATION NA
The Get Quit - Stay Quit Study
NCT01980485 COMPLETED NA
Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA